Salvage of Sildenafil Failures With Bremelanotide: A Randomized, Double-Blind, Placebo Controlled Study
![These highlights do not include all the information needed to use VYLEESI™ safely and effectively. See full prescribing information for VYLEESI™. VYLEESI (bremelanotide injection), for subcutaneous use Initial U.S. Approval: 2019 These highlights do not include all the information needed to use VYLEESI™ safely and effectively. See full prescribing information for VYLEESI™. VYLEESI (bremelanotide injection), for subcutaneous use Initial U.S. Approval: 2019](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=vyleesi-05.jpg&id=536911)
These highlights do not include all the information needed to use VYLEESI™ safely and effectively. See full prescribing information for VYLEESI™. VYLEESI (bremelanotide injection), for subcutaneous use Initial U.S. Approval: 2019
Phase I Randomized Placebo-controlled, Double-blind Study of the Safety and Tolerability of Bremelanotide Coadministered With Et
![Ultra-sensitive quantification of the therapeutic cyclic peptide bremelanotide utilizing UHPLC-MS/MS for evaluation of its oral plasma pharmacokinetics - ScienceDirect Ultra-sensitive quantification of the therapeutic cyclic peptide bremelanotide utilizing UHPLC-MS/MS for evaluation of its oral plasma pharmacokinetics - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0731708520302375-gr3.jpg)
Ultra-sensitive quantification of the therapeutic cyclic peptide bremelanotide utilizing UHPLC-MS/MS for evaluation of its oral plasma pharmacokinetics - ScienceDirect
![Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction ... Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction ...](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsj.ijir.3901139/MediaObjects/41443_2004_Article_BF3901139_Fig3_HTML.gif)
Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction ...
![Nu Image Medical on Twitter: "PT-141, also known as Bremelanotide, is peptide hormone that activates melanocortin receptors. This peptide has been shown to have substantial effect on libido, creating sexual arousal in Nu Image Medical on Twitter: "PT-141, also known as Bremelanotide, is peptide hormone that activates melanocortin receptors. This peptide has been shown to have substantial effect on libido, creating sexual arousal in](https://pbs.twimg.com/media/Epi_sMJXYAI1pHa.jpg)